First Department of Paediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
AJNR Am J Neuroradiol. 2013 Jan;34(1):5-13. doi: 10.3174/ajnr.A2832. Epub 2012 Jul 12.
MPS represents a group of rare hereditary disorders characterized by multisystem involvement due to intralysosomal GAG accumulation. Among various tissues, both the central and peripheral nervous system are affected in almost all types of the disease. Thus, brain and spinal MR imaging are valuable tools for the assessment of neurologic involvement, and there is evidence that they might be reliable markers demonstrating disease severity and efficacy of treatment options currently used in patients with MPS. We aimed to review the most prominent MR imaging features of patients with MPS, paying attention to the physiopathologic mechanisms responsible for these alterations. Along with the description of neuroimaging findings, existing data in relation to their correlation with the severity of neurologic involvement is discussed, while another topic of great importance is the effect of various therapeutic regimens in the progression of brain and spinal MR imaging alterations. Finally, recent data concerning MR spectroscopy studies in MPS are also critically discussed.
MPS 代表一组罕见的遗传性疾病,其特征是由于溶酶体内 GAG 积累导致多系统受累。在各种组织中,中枢和周围神经系统几乎在所有类型的疾病中都受到影响。因此,脑和脊髓磁共振成像 (MRI) 是评估神经受累的有价值的工具,有证据表明它们可能是可靠的标志物,可显示目前用于 MPS 患者的治疗方案的严重程度和疗效。我们旨在回顾 MPS 患者最突出的 MRI 特征,注意负责这些改变的病理生理机制。除了描述神经影像学发现外,还讨论了与神经受累严重程度相关的现有数据,另一个非常重要的主题是各种治疗方案对脑和脊髓 MRI 改变进展的影响。最后,还批判性地讨论了 MPS 中磁共振波谱研究的最新数据。